| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -9.5e-05 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 6.1e-05 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 4.6e-05 | 1 |